
PMC:7594251 / 41332-41407
Annnotations
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T409 | 19-23 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T410 | 57-68 | Chemical | denotes | vemurafenib | http://purl.obolibrary.org/obo/CHEBI_63637 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
546 | 57-68 | Chemical | denotes | vemurafenib | MESH:D000077484 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T287 | 0-75 | Sentence | denotes | The first marketed drug derived via the FBDD approach is vemurafenib [223]. |